Sargent Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Sargent Investment Group's LLY Position: Q1 2026 in Review
Sargent Investment Group reduced its Eli Lilly (LLY) stake by 5.8% in Q1 2026, selling an estimated $378K and leaving 6,066 shares worth $5.58M. The position accounts for 0.73% of the portfolio, ranked #29.
Sargent Investment Group first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $6.92M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sargent Investment Group held 6,066 shares of Eli Lilly worth $5.58M as of Q1 2026.
- Sargent Investment Group sold 373 Eli Lilly shares in Q1 2026, an estimated $378K.
- Eli Lilly made up 0.73% of Sargent Investment Group's portfolio in Q1 2026, its #29 holding.
- Sargent Investment Group first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
- Sargent Investment Group's Eli Lilly position peaked at $6.92M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.